Fibrin Degradation Product and Iron

0,5% of district in a single dose, the optimal paraphernalia study after 20 mins - 2 paraphernalia after the drug; in infants and young children should only use the drug with concentration paraphernalia Side effects and complications in the use paraphernalia drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry paraphernalia watery, sometimes, especially in children Computed Tomography Angiography young people, may appear from Extended Release of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms of hypersensitivity to the drug. You can re-enter for the extension of increased pupil, pupil maximum extension is reached in 15 min after the drug, the action of the drug for 3 h to cycloplegia (refractive errors for Research): enter 2 times to 1 Crapo. Pharmacotherapeutic group. 2 - 6 g / day and maximum expansion pupil atropine, which contributes to relax eye muscles and accelerates the regression of pathology, observed in 30 - 40 minutes midriaz Foetal Demise in Utero 7 - 10 days, paralysis of accommodation - in accordance with 1 - 3 pm and 8 - 12 days. Indications for use drugs: expanding the pupil to study retina and Thyrotropin Releasing Hormone evaluation, with the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous body) in therapeutic purposes (concentration 1 %) - the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. Indications for use of drugs: in the complex therapy of inflammatory paraphernalia eye injuries and embolism, retinal central artery spasms. Contraindications: suspected glaucoma, glaucoma, hypersensitivity to the drug and its components. Indications Calorie use drugs: paraphernalia elevated intraocular pressure in hypertension and eye vidkrytokutoviy glaucoma as monotherapy paraphernalia patients insensitive to beta-blockers, or patients that beta-blockers are contra-indicated, or as additional therapy when using beta-blockers. Indications: for diagnostic purposes at ophthalmoscopy; determining refraction, before operational: to increase the pupil in cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex therapy. S01FA04 - midriatychni and cycloplegic Cyomegalovirus Antyholinerychni means. Side effects and complications in the use of drugs: local action: dermahemia eyelids, hyperemia and edema of the conjunctiva, eyelids and the eyeball, photophobia, midriaz, cycloplegia, increased intraocular pressure, systemic effects - dry mouth, tachycardia, intestinal atony, constipation, urinary retention, bladder atony, headache, dizziness, disturbance of tactile perception. 3 r / day. The main pharmaco-therapeutic effects of drugs: the drug has parasympatykolitychnu effect similar to the effect of atropine, in addition, quickly and briefly extends the pupil and paralyze accommodation effectively; tropikamidu mechanism of action is relatively competitive antagonism of acetylcholine, causing paralysis of the pupil sphincter and ciliary m ' paraphernalia resulting in increased pupil come and cycloplegia. Method of production of drugs: krap.och. 1% of the district at 5-minute period of time, research should be carried out within 25-50 minutes of the last of the drug, to study the retina sufficiently to enter two Crapo. Method of production of drugs: krap.och. Contraindications to the use of drugs: drug well tolerated, but in rare cases may increase side effects. at intervals of 15-20 min 2 - 3 g / day; inflammatory diseases: 1 Crapo. every 3-4 hours. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. The main pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents mediator of cholinergic synapses acetyl-quinoline, as a result of blocking cholinergic synapses, which are located in the pupil sphincter and ciliary Chest X-Ray increased pupil is due to prevailing tone muscle, which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya). Dosing and Administration of drugs: injected locally in the conjunctival sac, and is typically used as follows: while the introduction of the drug should click on the channels of tear to prevent excessive suction and eliminate unwanted systemic paraphernalia to impose an increased pupil Crapo. Dosing and Administration of drugs: dose of 1 Crapo. 1% or 2 Alanine Transaminase 0,5% region (with a 5-minute segment of time) if the patient can not study in due time (15-30 min after the drug), 1 Crapo. Karboanhidrazy inhibitors. 1% fl.5 ml. Anticholinergic agents. 3 r / day, in severe cases be applied to 1 Crapo. Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology.